# Sutro Biopharma (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/sutro-biopharma-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 57 |
| Citations | 24,874 |
| City | South San Francisco |
| Country | US |
| Description | Sutro Biopharma (United States) is a research organisation in South San Francisco, US. OpenAlex records 145 works and 24,874 citations for it. 115 researchers list it as their most recent affiliation. |
| Homepage | https://www.sutrobio.com/ |
| OpenAlex ID | https://openalex.org/I4210152259 |
| Region | California |
| Researchers | 115 |
| ROR ID | https://ror.org/05xybd718 |
| Type | company |
| Works | 145 |

## University papers

- [Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers](https://scholariq.org/papers/comprehensive-analysis-of-the-transcriptional-and-mutational-landscape-of/)
- [Tumor Cells Chronically Treated with a Trastuzumab–Maytansinoid Antibody–Drug Conjugate Develop Varied Resistance Mechanisms but Respond to Alternate Treatments](https://scholariq.org/papers/tumor-cells-chronically-treated-with-a-trastuzumab-maytansinoid-antibody-drug/)
- [Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer](https://scholariq.org/papers/integrative-analysis-of-genomic-and-transcriptomic-characteristics-associated/)
- [Prognostic effects of <i>TERT</i> promoter mutations are enhanced by coexistence with <i>BRAF</i> or <i>RAS</i> mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients](https://scholariq.org/papers/prognostic-effects-of-i-tert-i-promoter-mutations-are-enhanced-by-coexistence/)

## University top topics

Showing 8 of 25.

- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [RNA and protein synthesis mechanisms](https://scholariq.org/topics/rna-and-protein-synthesis-mechanisms/)
- [Protein purification and stability](https://scholariq.org/topics/protein-purification-and-stability/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.